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Abstract. Objectives of this study were to explore the prevalence of subjective and objective dryness 
symptoms by smoking status in different age groups, to measure whole and minor saliva flow rates, 
and to evaluate the possible associations between salivary parameters, oral symptoms and the 
intensity of smoking in a sample of Hungarian adults. Repeated cross-sectional studies were conducted 
in 2003 (n=600) and 2014–2018 (n=301) among Hungarian adults visiting regional outpatient dental 
clinics of their residence where dentist interviewed them about their subjective sicca symptoms and 
cigarette smoking habits (non-smoker – NS, light smoker – LIS, moderate or heavy smoker – MHS), 
and measured unstimulated whole saliva flow rate (UWS), palatal- and labial minor saliva flow rates 
to assess xerostomia objectively. The severity of xerostomia was significantly higher in among 30–39-
year-old male smokers (44.8%; p=0.001), and among 18-29-year-old female smokers (52.9%; 
p=0.013), compared to their non-smoker counterparts (6.7% and 27.1%, respectively). UWS flow rate 
was significantly lower among 18-29-year-old MHS females compared to NS and LIS females in the 
same age group (p=0.019, p=0.015, respectively). Significantly increased palatal saliva flow rate was 
registered among 30–39-year-old MHS males compared to their NS counterparts (p=0.046). Our 
study highlighted that high intensity of smoking may cause xerostomia, a decrease in the UWS flow 
rate, and an increase in palatal saliva flow rate in some age groups, however, other sicca symptoms 
were mostly unrelated to the presence of dry mouth. 
 




Functions of saliva has an important role in regulation and maintenance of integrity of the oral 
tissues as well as oral and general health monitoring, including e.g. the use of salivary hormone assays 
in various fields of medicine and research [1,2].  Hyposalivation is  an objective finding of a decreased 
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 however, might be the clinical expression of severely decreased whole saliva flow rate [3,4]. The 
normal unstimulated whole saliva (UWS) flow rate is around 0.3 mL/min [4]. UWS flow rate ≤0.1 
ml/min is regarded as hyposalivation.  However, xerostomia, per se, is not always accompanied by 
reduced salivation. Nevertheless, the absence of xerostomia does not necessarily mean that there is 
adequate salivary secretion [5,6]. 
The prevalence of xerostomia in the population ranges from 5.5 to 46% [7].  Xerogenic factors 
could be systemic conditions and/or diseases (e.g., diabetes, irradiation therapy of the head and neck 
region, graft-versus-host disease, autoimmune diseases, depression, anxiety, stress, or malnutrition) 
and the use of several drugs [4,7,8]. Xerostomia is seldom a solitary symptom. When present for an 
extended period of time, it induces a wide variety of other oral sicca symptoms, like burning mouth, 
cheilitis, glossodynia, difficulty with eating dry foods, dysphagia, candidiasis, dysphonia and 
dysgeusia [4,5]. Moreover, numerous non-oral clinical signs can be associated with xerostomia as 
possible signs of generalized exocrinopathy, including ophtalmological (keratoconjunctivitis sicca), 
dermal (xeroderma), nasal, gynaecological dryness symptoms and fatigue, as a manifestation of sicca 
syndrome [4,5,9–11]. 
Existing studies indicate that tobacco use may have numerous unfavorable impact on oral health, 
including malodor, tooth discoloration, increased risk for caries, leukoplakia and oral cancer, delayed 
healing process in the oral cavity, and failure of dental implants [12]. The effect of smoking onto 
salivation and its possible association with dry mouth has controversial results in the literature. Toxic 
chemicals in cigarette smoke can cause structural and functional changes in the saliva, which is the 
first biological fluid exposed to cigarette smoke [13,14]. In an experimental study in Wistar rats, 
environmental tobacco smoke exposure led to substantial structural changes in the salivary glands 
which could significantly affect function [15]. Petrušić et al. found significant difference in the quality 
of human saliva, that is, the majority of smokers had thick saliva, while non-smokers had thin and 
watery saliva [16]. 
Some authors found positive correlation between smoking and salivary parameters, especially in 
the short term: mechanical, chemical and thermal stimulation of salivary glands during smoking can 
increase the amount of saliva [17,18]. Some studies reported that cigarette smoking can increase 
parotid saliva flow rate in humans [19,20], while others found increased salivation of the sublingual 
gland in rats, following cellular nicotinic receptor activation [21]. A recent study suggests that nicotine 
may enhance parotid salivation via increasing the intracellular Ca2+ concentration [22]. Regarding 
minor salivary gland secretions, Eliasson et al. found increased secretion (by 27%) among smokers 
which may be due to the local irritant effect of tobacco smoke resulting in an increased glandular 
output [23]. Moreover, in a Swedish study assessing dental status and smoking of the study population, 
male smokers had significantly higher stimulated salivary flow rates than male non-smokers; however, 
smokers reported more frequently dry mouth [24].  
On the other hand, other researchers could not detect any effect of smoking on salivary parameters 
and oral dryness symptoms, controlling for other conditions like alcohol consumption, dental status or 
obesity [3,25,26]. 
Several studies showed negative effects of smoking onto the subjective sicca symptoms and 
salivation. Anttila et al. found significant association between the subjective sensation of dry mouth 
and low unstimulated saliva flow rate in regular smokers [27]. Long-term smoking may adversely 
affect the function of the salivary glands which reflects in decreased amount and poorer quality of 
saliva [16,28]. Long-term use of tobacco especially smokeless forms may also cause significant 
decrease in the whole saliva flow rate and alter its pH towards acidic direction [18,29]. Regarding 
xerostomia, studies consistently found that current cigarette smoking contributes to the subjective 
feeling of oral dryness [30–32], although its association with gender, age and smoking intensity is still 
unclear.   
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There is scarce data in the literature of investigating the correlation between the intensity of 
smoking with salivary parameters and dryness symptoms. Additionally, in the current publications 
there is a limited evidence about the possible intra- and extra oral xerogenic effects of tobacco 
smoking. Therefore, the aims of this present study were to assess the prevalence of both subjective and 
objective dryness symptoms by smoking status in different age groups, to measure whole and minor 
saliva flow rates, and to evaluate the possible associations between salivary parameters, oral symptoms 
and the intensity of smoking. 
 
2.Material and methods 
 Repeated cross-sectional studies were conducted in 2003 (n=600) and 2014–2018 (n=301) 
among Hungarian adults visiting regional outpatient dental clinics of their residence. Participants were 
randomly selected by age and gender following the current regional distribution pattern of the 
Hungarian Statistical Office. All participants were inhabitants of the urban and rural areas of different 
regions in Hungary. Data were collected via personal interview and clinical examinations by dentists. 
Smokers using other tobacco products than conventional factory-made or roll-your-own cigarettes 
were excluded from the studies. Mean age of the aggregated sample (58.3% females) was 46 ± 16 
years (range from 18 to 92 years). 
This study has been approved by the Regional and Institutional Committee of Science and 
Research Ethics of Semmelweis University (No. 104/2003). All participants provided informed written 
consent to the study. 
Subjective sicca symptoms and cigarette smoking habits were assessed by a questionnaire during 
personal interview with a dentist right before a clinical examination. The questionnaire was developed 
for this study and included items about participants’ socio-demographics (age – categorized as 18–29, 
30–39, 40–59, and 60+ year-old age groups; gender), subjective symptoms of oral dryness and other 
related sicca symptoms (14 items for males and 16 items for females – table 1 and table 2 [5] – with 
response options severe/moderate/mild/no symptoms collapsed into dichotomous variable – yes/no – 
for some analyses), and cigarette smoking status. Current smokers were defined as those who have 
smoked every day in the past 30 days. Regarding smoking intensity (the number of cigarettes smoked 
per day – CPD), participants were categorized into moderate or heavy smoker (MHS – smoked ≥11 
CPD), light smoker (LIS – smoked 1–10 CPD), and non-smoker (NS) groups [33]. After completing 
the questionnaire, dental clinical examinations were conducted of which the measurement of 
unstimulated whole saliva (UWS) flow rate and minor salivary gland secretions were included in this 
present study. Collection of UWS was described previously by Márton et al. (2008) [5]. UWS flow 
rate was expressed in ml/min (which is nearly equivalent to g/min). A salivary secretion rate of 0.1 
ml/min or less was considered as an objective sign of salivary hypofunction (hyposalivation). Palatal- 
and labial minor salivary gland flow rates were measured with the Periotron 8000 (Oraflow Inc., 
Amityville, USA) device, using filter paper discs (Saliva paper, Oraflow Inc., Amityville, USA) with a 
standard diameter of 8 mm (area: 0.5 cm²). Measurements were carried out for 30 s on three main sites, 
according to the distribution of the minor salivary glands in the oral cavity [34]. The discs were placed 
individually on both sides of the hard palate in the region of the upper first molars, 15 mm palatally 
from the gingival margin (in case of palatal saliva flow), and on the oral surface of the lower lip (in 
case of labial saliva flow), 3 mm from the outer border of the lower labial mucosa, near the midline. 
The sites were previously dried with cotton gauze. After each measurement, paper discs were placed 
between the two electrodes of the Periotron device. The exact quantity of the absorbed saliva was 
recorded based on the electromagnetic properties of the absorbed micro-moisture. The Periotron 
readings were then transformed into µl/cm²/min values according to the previous calibration of the 
device with known quantities of distilled water [35–37]. 
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Statistical analysis  
 Descriptive characteristics of the sample, subjective sicca symptoms, UWS and minor salivary 
gland flow rates are presented in percentages, means, and standard deviations (SD). Independent 
samples t-test, one-way ANOVA, and χ2 test were used to test associations. All analyzes were 
performed using IBM SPSS version 24.0 software, and significance level was accepted at p<0.05.  
 
3. Results and discussions 
In overall, 35.9% of the sample was current smoker (43.4% of males and 30.5% of females, 
p<0.001). The intensity of smoking in different age groups by gender is presented in figure 1. Data 
show that 51.3% of female smokers and 60.7% of male smokers were MHS. Among females, daily 
smoking prevalence and intensity were highest in the 40–59-year-old age group (38.0% and 20.9%, 
respectively); while among males, the prevalence was highest in the 18–29-year-old age group 
(60.4%), and intensity in the 30–39-year-old age group (38.3%).    
 
Figure 1. Intensity of smoking by gender and age groups 
Table 1. Prevalence of intra- and extraoral sicca symptoms by smoking status in hungarian males 
Subjective symptoms in % 































1. Xerostomia 28.2 29.3 6.7 44.8 ** 22.2 31.5 42.0 50.0 28.6 35.6 
2. Dysphagia 12.8 10.3 10.0 13.8 11.1 18.5 12.4 36.4 * 11.7 17.2 
3.Glossodynia, burning mouth 10.3 6.9 13.3 3.5 7.9 13.0 1.2 9.1 6.6 9.2 
4. Dysphonia 35.9 46.6 26.7 27.6 25.4 33.3 27.2 18.2 28.2 35.0 
5. Dysgeusia 5.1 10.3 3.3 10.3 6.4 13.0 12.4 4.6 8.0 10.4 
6. Reduced saliva feeling 5.1 12.1 3.3 17.2 9.5 7.4 22.2 9.1 12.7 11.0 
7. Mucous saliva 18.0 29.3 16.7 24.1 22.2 18.5 18.5 9.1 19.3 22.1 
8. Increased caries activity 64.1 74.1 66.7 79.3 68.3 77.8 66.7 72.7 66.7 76.7 
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9. Nasal dryness 15.4 32.8 40.0 41.4 25.4 31.5 29.6 40.9 27.2 35.6 
10. Dryness of the eyes 28.2 20.7 13.3 17.2 22.2 16.7 19.8 13.6 21.1 17.8 
11. Itching, burning of the eyes 30.8 27.6 23.3 44.8 30.2 37.0 38.3 40.9 32.4 35.0 
12. Light sensitivity 43.6 34.5 36.7 51.7 36.5 37.0 44.4 63.6 40.9 41.7 
13. Xeroderma 30.8 48.3 43.3 44.8 39.7 42.6 49.4 54.6 42.3 47.2 
14. Fatigue 59.0 69.0 26.7 72.4 ** 50.8 53.7 60.5 50.0 52.6 62.0 
Bold letters indicate significant differences between smokers and non-smokers. S: smokers, NS: non-smokers. *p <0.05; **p<0.001 
 
Table 2. Prevalence of intra- and extraoral sicca symptoms by smoking status in hungarian females 
Subjective symptoms in % 































1. Xerostomia 27.1 52.9 * 39.7 25.9 43.5 43.8 52.3 38.9 42.7 41.9 
2. Dysphagia 10.2 20.6 13.2 14.8 22.9 25.0 16.8 22.2 17.3 21.3 
3.Glossodynia, burning mouth 6.8 8.8 5.9 7.4 11.5 12.5 6.5 11.1 8.2 10.0 
4. Dysphonia 50.9 47.1 42.7 25.9 34.4 41.3 38.3 61.1 39.7 41.9 
5. Dysgeusia 6.8 5.9 7.4 7.4 14.5 13.8 10.3 27.8 * 10.7 12.5 
6. Reduced saliva feeling 10.2 5.9 13.2 14.8 17.6 15.0 15.0 33.3 14.8 15.0 
7. Mucous saliva 20.3 32.4 17.7 14.8 10.7 16.3 12.2 16.7 14.0 19.4 
8. Increased caries activity 62.7 85.3 * 82.4 77.8 74.8 75.0 64.5 77.8 71.2 78.1 
9. Nasal dryness 40.7 32.4 29.4 44.4 42.0 31.3 33.6 44.4 37.0 34.4 
10. Dryness of the eyes 25.4 23.5 29.4 22.2 36.6 33.8 43.9 16.7 * 35.6 27.5 
11. Itching,  burning of the eyes 49.2 47.1 36.8 37.0 49.6 41.3 55.1 27.8 * 48.8 40.0 
12. Light sensitivity 54.2 44.1 52.9 40.7 60.3 65.0 50.5 38.9 55.1 53.1 
13. Xeroderma 72.9 79.4 70.6 70.4 71.0 68.8 79.4 72.2 73.7 71.3 
14. Vaginal dryness 6.8 8.8 11.8 3.7 22.9 15.0 22.4 11.1 18.1 11.3* 
15. Vaginal itching, burning,  
fungal infections 
15.3 26.5 25.0 14.8 18.3 11.3 12.2 5.6 17.3 13.8 
16. Fatigue 69.5 79.4 70.6 55.6 69.5 76.3 71.0 61.1 70.1 71.9 
Among smokers, 35.6% of males and 41.9% of the females reported subjective oral dryness 
(xerostomia), and 7.4% and 9.4% indicated it to be severe, respectively (table 1 and 2). These results 
did not differ significantly from related results of non-smokers (28.6%, 42.7%, 5.6% and 7.4%, 
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respectively). Among males, subjective feeling of fatigue was significantly higher in 30–39-year-old 
smokers compared to non-smokers (p=0.001), while dysphagia was more common in 60+ -year-old 
smokers compared to non-smokers (p=0.008). Among females, increased caries activity was reported 
in significantly higher proportion by 18–29-year-old smokers than by non-smokers in the same age 
group (p=0.021). Compared to 60+ -year-old non-smoker females, smoker females in the same age 
group indicated in significantly higher proportion to have dysgeusia (have difficulty with taste, 
p=0.040), xerophtalmia (p=0.030), and itching or burning sensation in their eyes (p=0.032). Regardless 
of age groups, greater proportion of non-smokers reported suffering from vaginal dryness than 
smokers (p=0.049). Other subjective sicca symptoms did not show significant differences between 
smoker and non-smoker males and females. Regarding the severity of xerostomia in different age 
groups, a significant increase was detected in subjective xerostomia among male smokers in the 30–
39-year-old age group (44.8%; p=0.001), and among female smokers in the 18–29-year-old age group 
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NS-F=non-smoker females, S-F=smoker females, NS-M=non-smoker males, S-M=smoker males. *p <0.05, **p<0.001 
Figure 2. Prevalence of light, moderate and severe xerostomia  according to smoking intensity among females 
and males in different age groups 
 
Figure 3. Unstimulated whole saliva (uws) flow rates according to smoking  
intensity in males in different age groups 
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Figure  4. Unstimulated whole saliva (uws) flow rates according to smoking 
 intensity in females in different age groups 
 
 Among males, UWS flow rates did not differed significantly according to smoking intensity either 
in the overall male sample or by considering age groups (Figure 3). In the overall female sample, there 
was no detectable significant difference in UWS flow rates concerning smoking intensity. However, 
we measured significantly lower UWS flow rate in the 18–29-year-old MHS female sample compared 
to NS and LIS females in the same age group (p=0.019; p=0.015, respectively) (Figure 4). 
When measuring minor salivary gland flow rates, significantly higher palatal saliva flow rate was 
registered among 30–39-year-old MHS males compared to their NS counterparts (p=0.046) (Figure  
5). The labial saliva flow rate of the overall MHS female sample was significantly lower compared to 
NS females (p=0.046), whereas LIS females in the age group of 60+ had significantly lower palatal 
saliva flow rate than NS females in the same age group (p=0.004) (Figure  6). No other significant 
differences have been recorded in the salivary parameters of NS, LIS and MHS males and females in 
other age groups. 
 
Figure 5. Minor salivary gland flow rates in males in different age groups 
 
Hyposalivation (UWS flow rate ≤ 0.1ml/min) was detected in 9.0% of non-smoker and 11.3% of 
smoker females, and 4.2% of non-smoker and 1.2% of smoker males (table 3). None of these results 
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differed significantly. Sixty-two out of all 901 patients (6.9%) showed hyposalivation. Most of them 
(82.3%) were females, and 48.4% of them belonged to the age group of 40-59 years.  
 
 
Figure 6. Minor salivary gland flow rates in females in different age groups 
 
Table 3. Prevalence of hyposalivation by smoking status in different age groups  
 
 
In our sample, the prevalence of smoking and intensity of smoking was higher than related national 
data based on representative samples of Hungarian adults [38]. A possible explanation for 
overrepresentation of smokers in our sample could be that smokers, particularly heavy smokers have 
poorer oral hygiene and increased risk for periodontal diseases [39], therefore they may attend more 
frequently to dental health service.  
In our sample, smokers in the youngest female age group and in the 30–39-year-old male age group 
complained significantly more about feeling of dry mouth, therefore, it is suspected that a positive 
correlation might exist between the intensity of smoking and xerostomia among younger adults.   
Although UWS flow rate was not decreased significantly in any smoker male age groups, palatal 
saliva flow rate increased significantly in the 30–39-year-old male MHS group. This increase can 
either be the consequence of an initial compensatory mechanism of the palatal minor salivary glands to 
xerostomia, or the other reason might be the direct stimulating effect of the high level of tobacco 
smoke to the palatal region’s glands. Eliasson et al. obtained similar results, and he suggested the local 
irritative effect of tobacco smoking onto the minor salivary glands as it increased their output [23].    
In females, prevalence of xerostomia was significantly higher in the 18-29-year-old age group, and 
besides, the UWS flow rate was significantly decreased in MHS females in this age group compared to 
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NS or LIS groups. Some studies found no correlation between xerostomia and decreased whole saliva 
flow rates in smokers [3,25,26], while other studies suggested that long term smoking results in lower 
salivary output [18,27,29,32]. Our results also support that heavy smoking may decrease salivation and 
contribute to the development of xerostomia and other sicca symptoms. However, the appearance of 
sicca symptoms in the affected organs may vary with age and other oral- and systemic health factors. 
Fatigue was also a significant subjective symptom in the male 30-39-year-old age group, which can be 
in connection with a number of different reasons: increased stress level, high level of heavy smoking, 
and furthermore, dry mouth. Dysphagia was significantly higher among male smokers in the 60+ age 
group. Since xerostomia did not differ significantly in the older age groups by smoking status, some 
other reasons might affect it, like edentulousness or tobacco smoke induced inflammation of the 
mucosa, although these assumptions need more investigation. Dysgeusia showed to be a significant 
sicca symptom in the female smoker 60+ age group. Since neither greater xerostomia prevalence nor 
decreased salivation could be detected in this group, a possible reason for gustatory disturbance could 
be the long-term tobacco smoke exposure  causing changes in taste buds’ forms, quantity and 
vascularization [40]. Contrary to the findings of Sendecka et al., xerophthalmia and additional burning 
and itching of the eyes were more common in the non-smoker female elderly participants (60+ age 
group) than in smokers. It suggests that other factors than smoking may cause these symptoms [41]. 
Our study explored that cigarette smoking might cause intraoral sicca symptoms like dysphagia and 
dysgeusia via other ways than provoking oral dryness. Further studies are needed to obtain a clearer 
explanation for our results regarding intra- and extraoral sicca symptoms other than oral dryness. 
Future studies should assess whether sicca symptoms have associations with provocative or 
inflammatory effects of tobacco smoke. 
 
4. Conclusions 
 This study highlighted that high intensity of smoking may cause xerostomia, a decrease in the 
UWS flow rate, and an increase in palatal saliva flow rate in some age groups.  However, other sicca 
symptoms were mostly unrelated to the presence of dry mouth. Besides regular dental and 
stomatooncological screening during dental checkups [42], it is recommended for dentists to routinely 
assess the smoking status of their patients and possible oral dryness symptoms of smokers. Moreover, 
dental healthcare professionals should be further encouraged to educate patients about the harmful oral 
health effects of smoking, in order to support cessation strategies to prevent adverse dental and oral 
consequences of these conditions [43]. 
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